CCP
AMGN icon

Cardan Capital Partners’s Amgen AMGN Stock Holding History

Cardan Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$266K Sell
1,253
-4
-0.3% -$921 0.03% 214
2021
Q2 		$306K Hold
1,257
– – 0.03% 204
2021
Q1 		$313K Buy
1,257
+100
+9% +$23.9K 0.04% 179
2020
Q4 		$266K Hold
1,157
– – 0.03% 190
2020
Q3 		$294K Hold
1,157
– – 0.04% 182
2020
Q2 		$273K Buy
+1,157
New +$264K 0.04% 190

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cardan Capital Partners's AMGN Position: Q3 2021 in Review

Cardan Capital Partners reduced its Amgen (AMGN) stake by 0.32% in Q3 2021, selling an estimated $921 and leaving 1,253 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #214.

Cardan Capital Partners first reported a position in AMGN in Q2 2020 and has held it in 6 quarters since. The position peaked at $313K in Q1 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Cardan Capital Partners held 1,253 shares of Amgen worth $266K as of Q3 2021.
  • Cardan Capital Partners sold 4 Amgen shares in Q3 2021, an estimated $921.
  • Amgen made up 0.03% of Cardan Capital Partners's portfolio in Q3 2021, its #214 holding.
  • Cardan Capital Partners first reported a position in Amgen in Q2 2020 and has held it in 6 quarters since.
  • Cardan Capital Partners's Amgen position peaked at $313K in Q1 2021.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.